Key Takeaways

  • Publication Rights Are Contractual: Dr. Marie-Pierre St-Onge confirms that research contracts almost universally protect a scientist's right to publish findings, regardless of whether the results favor the funder. Without the right to publish, she says, there is no point in doing the research.
  • Null Results Are a Universal Problem: The difficulty in publishing studies with "null results" (i.e., no significant effect found) is a bias that plagues all scientific fields and funding sources, not just industry-sponsored work.
  • Misconduct Is Personal, Not Systemic: Scientific misconduct, such as falsifying data, is a rare issue of individual integrity. St-Onge notes that reports of such misconduct are found in both industry-funded and NIH-funded studies.
  • Frito-Lay Funded Polyunsaturated Fat Research: An anecdote highlighted how Frito-Lay funded research on the health effects of their products after switching to corn oil, which is higher in polyunsaturated fats. This shows a willingness to study their own products, even if the results are unexpected.

The Contractual Right to Publish (and the Myth of Buried Results)

Many founders assume industry money always taints research. The immediate thought is usually that if a company funds a study, they will bury any bad news. But Dr. Marie-Pierre St-Onge, a respected researcher, pushes back hard on this. She explains that in her experience, “Your right to publish... that's in the contract.” If a researcher could not publish, she asks, “why'd you do research?” It is a fundamental tenet that protects scientific integrity.

The bigger challenge is not censorship, but a universal publishing bias. St-Onge points out that “some of the studies that I haven't been able to publish have been funded by industry that have had null results.” This means the research found no significant effect. However, she quickly clarifies, “that's a null result issue. It's not necessarily unique to industry funded studies.” The scientific community, across all funding sources, struggles to publish results that do not show a clear "positive" or "negative" finding, even though null results are just as crucial for building accurate knowledge.

Misconduct: An Individual Failing, Not a Funding Problem

Another knee-jerk reaction against industry-funded studies is the fear of widespread data manipulation. Andrew Huberman himself put it bluntly, stating that people who falsify data are "legitimately sick." St-Onge agrees, but insists that such misconduct is not tied to the source of funding. She cites that "NIH reports of scientific misconduct" also exist, where “principal investigator[s] falsified data that have been published in a specific paper.”

This reveals a crucial distinction: scientific integrity is about the individual researcher and the systems of peer review, not the logo on the check. Diverse funding streams are essential for robust science. If we dismiss an entire category of research out of hand, we cripple our ability to gain knowledge, especially in areas where industry has the resources and incentive to study their own products. Think of Frito-Lay, which funded a study after changing to corn oil for their Doritos, Fritos, and Cheetos products.

What to Do With This

Next time you encounter industry-funded research, pause before dismissing it. Instead of asking who funded it, ask: Did the study design account for potential biases? Were the methods sound? And most importantly, review the actual results. Your job as a builder is to use the best available data, not to filter by funding source before evaluating the science itself.